Drug Topics November 13, 2024
Brian Nowosielski

An FDA representative gave a presentation on her organization’s recent updates regarding drug supply chain rules and regulations.

In order to maintain the integrity of the US drug supply chain, it’s the shared goal of pharmacists, manufacturers, and regulators to focus on protecting all pharmaceutical products, and ultimately the patient receiving those products, from harm. From enforcement actions and warning letters to new programs furthering the organization’s mission, the FDA is working around the clock with several supply chain contributors to ensure safety and security within US pharmacies.

“We need to make sure that our federal requirements, layered with our state requirements, maintain the integrity of the pharmaceutical supply chain to protect the product and ultimately protect the patient. That’s...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Conferences / Podcast, FDA, Govt Agencies, Pharma, Pharma / Biotech, Trends
Supporting the Development of Drugs for Rare Diseases — The Importance of Regulatory Transparency
Opinion: To fight for those with rare diseases, Trump must reform and modernize the FDA thoughtfully
5 Rare Diseases That Now Have Their First FDA-Approved Treatments
FDA’s Recent Guidance on Accelerated Approval and Implications for Rare Diseases
This Bill Could Make It Legal for AI to Prescribe Medicine

Share This Article